Oagwin Pharmaceuticals Private Limited
About Oagwin Pharmaceuticals Private Limited
Data last updated:
Oagwin Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 05 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2020PTC139208. Its GSTIN is 37AADCO3111G1ZU (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Venu Gopal Davuluri and Bolla Divya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.3A Roja Nagar Ext Madhavaram, Chennai, Tamil Nadu, India – 600060.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.66 Lakh, a decline of 14% compared to the previous year. For the same year it recorded EBITDA of ₹240 (EBITDA margin 0.1%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years.
Company details
Contact details
Oagwin Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressNo.3A Roja Nagar Ext Madhavaram, Chennai, Tamil Nadu, India – 600060
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Oagwin Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oagwin Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Oagwin Pharmaceuticals Private Limited, buy the company report.
Financials of Oagwin Pharmaceuticals Private Limited
FY 2025 filings availableOagwin Pharmaceuticals Private Limited reported revenue of ₹4.66 Lakh (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 18% over three years, including a 14% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹240 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.1% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oagwin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Oagwin Pharmaceuticals Private Limited
Oagwin Pharmaceuticals has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venu Gopal Davuluri | Director | 04 Nov 2022 | 4 Years 0 Months | Current |
| Bolla Divya Also directs: Pavan Oagwin Pharmaceuticals Private Limited | Director | 04 Nov 2022 | 4 Years 0 Months | Current |
| Swetha Thatisetti | Additional Director | 01 Dec 2022 | 3 Years 11 Months | Current |
| Sadikha Shaik | Additional Director | 01 Dec 2022 | 3 Years 11 Months | Current |
| Thatisetti Venkata Pavan Kumar Also directs: Pavan Oagwin Pharmaceuticals Private Limited | Director | 04 Nov 2022 | 4 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Oagwin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oagwin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oagwin Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AADCO3111G1ZU | Andhra Pradesh | Active | 14 Nov 2020 |
To see the full GST registrations and return filing status of Oagwin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Oagwin Pharmaceuticals Private Limited has 8 board changes on record since 2022: 5 appointments and 3 cessations. The latest: Sadikha Shaik was appointed as Additional Director on 01 Dec 2022.
Frequently asked questions
Oagwin Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 05 November 2020 (6+ years old) and is registered under CIN U74999TN2020PTC139208.
Oagwin Pharmaceuticals has 5 current directors:
- Venu Gopal Davuluri - Director
- Bolla Divya - Director
- Swetha Thatisetti - Additional Director
- Sadikha Shaik - Additional Director
- Thatisetti Venkata Pavan Kumar - Director
The latest financial statements of Oagwin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Oagwin Pharmaceuticals is 37AADCO3111G1ZU, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Oagwin Pharmaceuticals is U74999TN2020PTC139208. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oagwin Pharmaceuticals was incorporated on 05 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
Sadikha Shaik was appointed as Additional Director on 01 Dec 2022. Swetha Thatisetti was appointed as Additional Director on 01 Dec 2022. Mohammad Ali Shaik ceased to be Director on 30 Nov 2022. Oagwin Pharmaceuticals has 8 board changes on record in total.
The registered office of Oagwin Pharmaceuticals is at No.3A Roja Nagar Ext Madhavaram, Chennai, Tamil Nadu, India – 600060.
Oagwin Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
Oagwin Pharmaceuticals can be reached at its registered office: No.3A Roja Nagar Ext Madhavaram, Chennai, Tamil Nadu, India – 600060.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
